Literature DB >> 27586671

Postoperative endophthalmitis incidence after intravitreal therapy: a comparison of two different preoperative antibiotic prophylaxis.

Sergio Piscitello1, Maria Vadalà2.   

Abstract

Prevention of postoperative endophthalmitis (POE) is a goal of every ophthalmic procedure and also in intravitreal therapy (IVT). This comparative retrospective study targets whether systemic and topical preoperative antibiotic prophylaxis (PAP) regimen does prevent POE after IVT in a higher rate compared with topical PAP alone. Out of 6111 IVT performed over a period of 103.5 months, in the study group A patients were treated with systemic and topical PAP (2881 IVT), and in the study group B patients were treated only with topical PAP (3230 IVT). Intravitreal drugs were anti-VEGF, triamcinolone and dexamethasone implants. The incidence of POE in group A (1/2881 or 0.035 % per injection) was not significantly different (P = 0.4) from that in suite B (1/3230 or 0.031 % per injection). Our study states that systemic PAP does not modify the risk of postoperative endophthalmitis in patients treated with IVT.

Entities:  

Keywords:  Antibiotic prophylaxis; Endophthalmitis; Incidence; Intravitreal therapy

Mesh:

Substances:

Year:  2016        PMID: 27586671     DOI: 10.1007/s10792-016-0307-3

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  40 in total

1.  Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.

Authors:  Maiko Inoue; Shinichiro Kobayakawa; Chie Sotozono; Hideki Komori; Kumiko Tanaka; Yuzo Suda; Hiroyuki Matsushima; Shigeru Kinoshita; Tadashi Senoo; Tetsuo Tochikubo; Kazuaki Kadonosono
Journal:  Ophthalmologica       Date:  2011-07-29       Impact factor: 3.250

2.  Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates.

Authors:  A R Anand; K L Therese; H N Madhavan
Journal:  Indian J Ophthalmol       Date:  2000-06       Impact factor: 1.848

3.  Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies.

Authors:  Colin A McCannel
Journal:  Retina       Date:  2011-04       Impact factor: 4.256

4.  Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask.

Authors:  Hiroyuki Shimada; Takayuki Hattori; Ryusaburo Mori; Hiroyuki Nakashizuka; Kyoko Fujita; Mitsuko Yuzawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-07       Impact factor: 3.117

5.  Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.

Authors:  Abdhish R Bhavsar; Joseph M Googe; Cynthia R Stockdale; Neil M Bressler; Alexander J Brucker; Michael J Elman; Adam R Glassman
Journal:  Arch Ophthalmol       Date:  2009-12

6.  Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.

Authors:  Jae Lim Chung; Eun Hye Lim; Sang Wroul Song; Byung Yeop Kim; Joon H Lee; Francis S Mah; Kyoung Yul Seo
Journal:  Cornea       Date:  2013-07       Impact factor: 2.651

7.  Reduction of endophthalmitis rate after cataract surgery with preoperative 5% povidone-iodine.

Authors:  Adisak Trinavarat; La-ongsri Atchaneeyasakul; Cherdchai Nopmaneejumruslers; Kantima Inson
Journal:  Dermatology       Date:  2006       Impact factor: 5.366

8.  Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting.

Authors:  Suman Pilli; Athanasios Kotsolis; Richard F Spaide; Jason Slakter; K Bailey Freund; John Sorenson; James Klancnik; Michael Cooney
Journal:  Am J Ophthalmol       Date:  2008-03-10       Impact factor: 5.258

9.  Endophthalmitis after intravitreal injection: decreasing incidence and clinical outcome-8-year results from a tertiary ophthalmic referral center.

Authors:  Martin M Nentwich; Yazmin Yactayo-Miranda; Fabian Schwarzbach; Armin Wolf; Anselm Kampik; Herminia Mino de Kaspar
Journal:  Retina       Date:  2014-05       Impact factor: 4.256

Review 10.  Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review.

Authors:  Amelie Pielen; Nicolas Feltgen; Christin Isserstedt; Josep Callizo; Bernd Junker; Christine Schmucker
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.